Online citations, reference lists, and bibliographies.

Resveratrol Bioavailability And Toxicity In Humans.

Charles-Henry Cottart, V. Nivet-Antoine, C. Laguillier-Morizot, J. Beaudeux
Published 2010 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Numerous data are now available on the beneficial properties of the polyphenolic compound resveratrol including its anti-inflammatory and antitumor effects. However, few studies have been performed with resveratrol in humans, and the results of these studies appear fragmentary and sometimes contradictory due to variations in conditions of administration, protocols and methods of assessment. This review article presents the results of recent studies investigating the pharmacokinetics, bioavailability, and toxicity of resveratrol in humans. Resveratrol is well absorbed, rapidly metabolized, mainly into sulfo and glucuronides conjugates which are eliminated in urine. Resveratrol seems to be well tolerated and no marked toxicity was reported. These data are important in the context of human efficacy studies, and they provide further support for the use of resveratrol as a pharmacological drug in human medicine.
This paper references
10.1124/mol.108.052019
Intestinal Breast Cancer Resistance Protein (BCRP)/Bcrp1 and Multidrug Resistance Protein 3 (MRP3)/Mrp3 Are Involved in the Pharmacokinetics of Resveratrol
K. van de Wetering (2009)
10.1002/CHIN.200828249
Structure-activity relationship of trans-resveratrol and its analogues.
Z. Ovesná (2005)
10.1002/jps.21880
Resveratrol-loaded calcium-pectinate beads: effects of formulation parameters on drug release and bead characteristics.
S. Das (2010)
10.5414/CPP46564
Effect of food on the pharmacokinetic profile of trans-resveratrol.
M. Vaz-da-Silva (2008)
10.1038/nature01960
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
K. Howitz (2003)
10.1002/MNFR.200500003
Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats.
Elisabeth Wenzel (2005)
10.1097/00001648-199803000-00017
Postterm delivery: a challenge for epidemiologic research.
K. Shea (1998)
10.1021/AC0484272
Uptake of diet resveratrol into the human low-density lipoprotein. Identification and quantification of resveratrol metabolites by liquid chromatography coupled with tandem mass spectrometry.
M. Urpi-Sardà (2005)
10.1016/j.fct.2009.06.002
Safety studies conducted on high-purity trans-resveratrol in experimental animals.
Lonnie D Williams (2009)
10.1002/JPS.20156
Resveratrol glucuronides as the metabolites of resveratrol in humans: characterization, synthesis, and anti-HIV activity.
L. Wang (2004)
10.1021/JF049521M
Determination of piceid and resveratrol in Spanish wines deriving from Monastrell (Vitis vinifera L.) grape variety.
Juan F Moreno-Labanda (2004)
10.1016/S0378-4347(01)00142-6
Ultrasensitive assay for three polyphenols (catechin, quercetin and resveratrol) and their conjugates in biological fluids utilizing gas chromatography with mass selective detection.
G. Soleas (2001)
10.1016/0271-5317(96)00032-2
Bioavailability, metabolism and physiological impact of 4-oxo-flavonoids
C. Manach (1996)
10.1097/00001648-199803000-00014
Alcohol and Mortality in Middle‐Aged Men from Eastern France
S. Renaud (1998)
Synthesis and biological properties of new stilbene deri
P. de Medina
10.1016/j.freeradbiomed.2008.12.023
Resveratrol metabolites in urine as a biomarker of wine intake in free-living subjects: The PREDIMED Study.
R. Zamora-Ros (2009)
10.1079/BJN20061810
Distribution of [3H]trans-resveratrol in rat tissues following oral administration.
Manal Abd El-Mohsen (2006)
10.1021/JF010812U
An LC-MS method for analyzing total resveratrol in grape juice, cranberry juice, and in wine.
Y. Wang (2002)
10.1021/JF030582E
Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice.
X. Meng (2004)
10.1002/mnfr.200800177
Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers.
L. Almeida (2009)
10.1152/ajpregu.1998.275.1.R212
Plasma metabolites of quercetin and their antioxidant properties.
C. Morand (1998)
10.1093/JN/134.12.3219
Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in colorectal cancer: key role of polyamines?
F. Wolter (2004)
10.1248/BPB.30.1130
Resveratrol oligomers from Vitis amurensis attenuate beta-amyloid-induced oxidative stress in PC12 cells.
M. H. Jang (2007)
10.1016/j.jpba.2009.03.026
Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC.
M. Juan (2010)
10.1373/CLINCHEM.2006.071936
HPLC-tandem mass spectrometric method to characterize resveratrol metabolism in humans.
M. Urpi-Sardà (2007)
10.1373/CLINCHEM.2005.065870
Diagnostic performance of urinary resveratrol metabolites as a biomarker of moderate wine consumption.
R. Zamora-Ros (2006)
10.1158/1055-9965.EPI-07-0022
Phase I Dose Escalation Pharmacokinetic Study in Healthy Volunteers of Resveratrol, a Potential Cancer Chemopreventive Agent
D. Boocock (2007)
10.1124/dmd.104.000885
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
T. Walle (2004)
J. Biol. Chem
(2005)
10.1016/j.ijpharm.2009.03.021
Resveratrol-loaded polymeric micelles protect cells from Abeta-induced oxidative stress.
Xiaowei Lu (2009)
10.1021/JM0498194
Synthesis and biological properties of new stilbene derivatives of resveratrol as new selective aryl hydrocarbon modulators.
P. de Médina (2005)
10.1002/mnfr.200700290
Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C/O-conjugated diglucuronides - two novel resveratrol metabolites in human plasma.
Alexander Burkon (2008)
Concentration of the Phytoalexin Resveratrol in Wine
E. Siemann (1992)
10.1021/JM030785U
Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents.
M. Roberti (2003)
10.1038/nature05354
Resveratrol improves health and survival of mice on a high-calorie diet
J. Baur (2006)
10.1093/JN/132.2.257
The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful.
M. Juan (2002)
10.1002/MNFR.200500010
Metabolism and bioavailability of trans-resveratrol.
Elisabeth Wenzel (2005)
10.1093/TOXSCI/KFH263
Resveratrol-associated renal toxicity.
J. Crowell (2004)
10.1016/S0021-9673(00)00211-9
Analysis of resveratrol in wine by capillary electrophoresis.
X. Gu (2000)
10.1016/S0009-9120(02)00397-1
Absorption of three wine-related polyphenols in three different matrices by healthy subjects.
D. Goldberg (2003)
10.1038/sj.bjc.6600197
The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1
G. Potter (2002)
10.1002/MNFR.200500002
Bioavailability of trans-resveratrol from red wine in humans.
P. Vitaglione (2005)
10.1158/1940-6207.CAPR-08-0160
Cancer Prevention and Treatment with Resveratrol: From Rodent Studies to Clinical Trials
Anupam Bishayee (2009)
Distribution of [ 3 H ] trans-resveratrol in rat tissues following oral administration
M. A. El-Mohsen (2006)
10.1016/j.aca.2008.12.003
Simple spectrophotometric assessment of the trans-/cis-resveratrol ratio in aqueous solutions.
L. Camont (2009)
10.1016/S0076-6879(01)35238-2
Measurement of trans-resveratrol, (+)-catechin, and quercetin in rat and human blood and urine by gas chromatography with mass selective detection.
G. Soleas (2001)
10.1016/j.canlet.2008.03.057
Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives.
J. Kundu (2008)
Synthesis and biological properties of new stilbene deri- Mol. Nutr
P. de Medina (2010)
10.1021/jf901716j
Identification and bioactivities of resveratrol oligomers and flavonoids from Carex folliculata seeds.
L. Li (2009)
10.1124/JPET.102.033340
Metabolism and Disposition of Resveratrol in Rats: Extent of Absorption, Glucuronidation, and Enterohepatic Recirculation Evidenced by a Linked-Rat Model
J. Marier (2002)
10.1021/JF981024G
Piceid, the major resveratrol derivative in grape juices.
A. Romero-Pérez (1999)
Deglucuronidation of a flavonoid, luteolin monoglucuronide, during inflammation.
K. Shimoi (2001)
10.1021/jf00050a003
Direct HPLC Analysis of cis- and trans-Resveratrol and Piceid Isomers in Spanish Red Vitis vinifera Wines
R. M. Lamuela-Raventós (1995)
10.1016/J.JCHROMB.2006.10.017
Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography.
D. Boocock (2007)
10.1002/MNFR.200400081
Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis.
S. Ulrich (2005)
10.1021/JF9900884
Determination of stilbenes (trans-astringin, cis- and trans-piceid, and cis- and trans-resveratrol) in Portuguese wines.
M. T. Ribeiro de Lima (1999)
10.1016/S0024-3205(03)00096-1
Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration.
X. Vitrac (2003)
10.1016/S0006-291X(02)00407-2
Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway.
M. Yoshizumi (2002)
10.1074/jbc.M508246200
Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides*
P. Marambaud (2005)
10.1002/CLC.4960200504
Alcohol, ischemic heart disease, and the french paradox
J. Constant (1997)



This paper is referenced by
10.1177/1535370212473704
Diabetic complications in pregnancy: is resveratrol a solution?
Chandra K Singh (2013)
10.3892/ijo.2013.2141
Resveratrol enhances ionizing radiation-induced premature senescence in lung cancer cells
Hongmei Luo (2013)
10.3390/nu9010045
Resveratrol, Potential Therapeutic Interest in Joint Disorders: A Critical Narrative Review
Christelle Nguyen (2017)
10.1016/j.jpba.2011.10.023
Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC-MS/MS and their pharmacokinetics in dogs.
M. Muzzio (2012)
10.3390/nu11010143
Resveratrol and Its Human Metabolites—Effects on Metabolic Health and Obesity
M. Springer (2019)
10.1016/j.ejps.2015.09.007
Resveratrol-loaded liposomes for topical treatment of the vaginal inflammation and infections.
May Wenche Jøraholmen (2015)
10.1016/j.nutres.2011.09.028
Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment.
K. Fujitaka (2011)
10.1002/mnfr.201200067
Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets in db/db mice.
G. Do (2012)
10.1016/j.fct.2015.03.028
Cytoprotective effect of resveratrol diastereomers in CHO-K1 cells exposed to beauvericin.
B. Mallebrera (2015)
10.1016/j.abb.2010.12.030
The grape antioxidant resveratrol for skin disorders: promise, prospects, and challenges.
M. Ndiaye (2011)
10.1016/j.semcancer.2015.03.007
Therapeutic targeting of replicative immortality
P. Yaswen (2015)
10.1016/j.ejphar.2012.08.024
Resveratrol mediates anti-atherogenic effects on cholesterol flux in human macrophages and endothelium via PPARγ and adenosine.
I. Voloshyna (2013)
10.1002/med.21565
Health benefits of resveratrol: Evidence from clinical studies.
Akhand Pratap Singh (2019)
CArG-driven GADD 45 α activated by resveratrol inhibits lung cancer cells
Qiwen Shi (2015)
RESVERATROL: RECOMMENDING ITS WIDE INCREASE – A PREMATURE DECISION OR NOT? A REVIEW
Marieta Georgieva (2015)
10.1002/jsfa.9632
Improved extraction of resveratrol and antioxidants from grape peel using heat and enzymatic treatments.
J. Averilla (2019)
10.1007/s12035-016-9839-9
Resveratrol and Alzheimer’s Disease: Mechanistic Insights
T. Ahmed (2016)
10.1111/febs.12112
Modulation of bacterial ghosts – induced nitric oxide production in macrophages by bacterial ghost‐delivered resveratrol
V. Koller (2013)
10.3906/sag-1501-109
Effects of resveratrol and cigarette smoking onbone healing: histomorphometric evaluation.
Özge Kolkesen Şahin (2016)
10.1007/s12170-012-0289-2
Resveratrol: Effects on Lipids and Cardiovascular Risk
Evan Paul Cherniack (2013)
10.1002/ptr.5539
Effect of Resveratrol Treatment on the Pharmacokinetics of Diclofenac in Healthy Human Volunteers.
Satish Kumar Bedada (2016)
10.1007/s10847-016-0657-5
Preclinical pharmacokinetics comparison between resveratrol 2-hydroxypropyl-β-cyclodextrin complex and resveratrol suspension after oral administration
Zhiqian Yang (2016)
Effets des polyphénols de vin rouge sur la prolifération cellulaire et sur le métabolisme du resvératrol
Frédéric Mazué (2011)
10.1080/10408363.2017.1343274
Role of resveratrol in the management of insulin resistance and related conditions: Mechanism of action
Ebrahim Abbasi Oshaghi (2017)
10.3109/09637486.2014.917152
A novel red grape cells complex: health effects and bioavailability of natural resveratrol
M. Azachi (2014)
10.3390/ijms20020398
Nanostructured Chitosan-Based Biomaterials for Sustained and Colon-Specific Resveratrol Release
N. Iglesias (2019)
10.4149/BLL_2012_105
Plant polyphenols in prevention of heart disease.
E. Ginter (2012)
10.1371/journal.pone.0109048
Resveratrol Modulates Cytokine-Induced JAK/STAT Activation More Efficiently than 5-Aminosalicylic Acid: An In Vitro Approach
Diana Serra (2014)
10.1155/2014/938712
Leukocyte Production of Inflammatory Mediators Is Inhibited by the Antioxidants Phloretin, Silymarin, Hesperetin, and Resveratrol
J. B. Fordham (2014)
10.22312/sbed.95053
Deneysel sigara modelinde resveratrolün total oksidan/antioksidan kapasite üzerine etkilerinin araştırılması
Özge Sahin (2015)
10.1007/978-94-007-4917-7
Novel Apoptotic Regulators in Carcinogenesis
G. Chen (2012)
10.1038/aps.2015.46
Resveratrol analogue 3,4,4′-trihydroxy-trans-stilbene induces apoptosis and autophagy in human non-small-cell lung cancer cells in vitro
L. Zhang (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar